Movano (NASDAQ:MOVE) Releases Earnings Results, Misses Expectations By $1.95 EPS

Movano (NASDAQ:MOVE) announced its quarterly earnings data on Friday. The technology company reported ($5.12) EPS for the quarter, missing analysts’ consensus estimates of ($3.17) by ($1.95), Zacks reports.

Here are the key takeaways from Movano’s conference call:

• Contracted annualized recurring revenue on live compute reached approximately $22 million as of August 2026, supported by fixed-term, take-or-pay contracts. The company also announced a Blackwell expansion funded through debt, customer prepayment, and existing cash.
• Second-quarter revenue was only $3.8 million, while adjusted EBITDA was negative $3.2 million and net loss was $12.8 million. Management emphasized that revenue depends on capacity being live and handed over, so signed contracts do not immediately translate into reported revenue.
• Corvex Token Factory version 1 entered closed alpha, with additional releases planned for the third and fourth quarters. The company is positioning the platform around lower-cost open-weight model inference, automation, reliability, and confidential computing, but the products remain early-stage.
• Management acknowledged substantial execution and financing risks, including the need for significant additional capital, customer concentration, unremediated material weaknesses in internal controls, and ongoing non-cash stock compensation charges. Following preferred-stock conversions, the company had approximately 56.6 million common shares on an as-converted basis, while a resale registration covers up to 53.4 million shares held by existing investors.

Movano Trading Up 5.1%

Shares of NASDAQ:MOVE traded up $0.57 during mid-day trading on Friday, hitting $11.72. The stock had a trading volume of 165,560 shares, compared to its average volume of 627,721. The company’s 50 day moving average is $16.17 and its 200-day moving average is $15.70. Movano has a 12-month low of $3.44 and a 12-month high of $26.72. The company has a debt-to-equity ratio of 4.28, a quick ratio of 2.04 and a current ratio of 2.14. The company has a market cap of $323.89 million, a PE ratio of -0.85 and a beta of 0.88.

Analyst Ratings Changes

Separately, Wall Street Zen raised Movano from a “sell” rating to a “hold” rating in a research report on Sunday, May 24th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, Movano presently has an average rating of “Sell”.

Institutional Trading of Movano

An institutional investor recently bought a new position in Movano stock. Citadel Advisors LLC bought a new position in Movano Inc. (NASDAQ:MOVE) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 49,262 shares of the technology company’s stock, valued at approximately $28,000. Citadel Advisors LLC owned 5.94% of Movano as of its most recent SEC filing. Institutional investors own 16.64% of the company’s stock.

Key Headlines Impacting Movano

Here are the key news stories impacting Movano this week:

• Positive Sentiment: The stock’s resilience after the earnings release may indicate that investors had already discounted substantial losses or are focused on Movano’s longer-term wearable-health technology opportunity rather than the quarter’s results.
• Neutral Sentiment: Broader market sentiment was soft as the S&P 500 and Nasdaq 100 declined following weaker consumer sentiment and retail-sales data. This creates a less supportive backdrop for speculative technology stocks, although the market weakness was not specific to Movano. Stock Market Today: SPY, QQQ Stumble as Consumer Sentiment Slips and Retail Sales Slide
• Negative Sentiment: Movano reported a quarterly loss of $5.12 per share, missing the analyst consensus estimate of a $3.17 loss by $1.95. The sizable earnings miss reinforces concerns about cash burn, the company’s path to profitability and the need for potential future financing. Movano quarterly earnings press release

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.